x

Innoviva, Inc. (Nasdaq:INVA)

Health Care/Life Sciences • Pharmaceuticals
CIK 1080014
Company

Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.

Address
1350 Old Bayshore Highway
Suite 400
Burlingame, California 94010
Employees
112
Stock Info
Close
$17.61
Day Range
17.43 - 17.74
52 Week Range
14.33 - 21.28
Average volume
578.84K
Short Interest
8.98M (02/14/25)
% of Float Shorted
14.48%
Market Cap
$1.1B
Revenue
$324.26M
Net Income
$179.72M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
84.18
EPS
$0.21
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Director
Odysseas Demosthenes Kostas
Independent Director
Derek A. Small
Independent Director
Sapna R. Srivastava
Independent Director
Jules Haimovitz
Lead Independent Director
Sarah J. Schlesinger
SEC filings
DateFormEvent
22 Nov, 2024 4
14 Nov, 2024 SC 13D/A
6 Nov, 2024 10-Q
6 Nov, 2024 8-K
1 Nov, 2024 UPLOAD
26 Sep, 2024 CORRESP
13 Sep, 2024 UPLOAD
22 Aug, 2024 4
31 Jul, 2024 10-Q
31 Jul, 2024 8-K
20 Jun, 2024 8-K
20 Jun, 2024 4
20 Jun, 2024 4
20 Jun, 2024 4
20 Jun, 2024 4
20 Jun, 2024 4
20 Jun, 2024 4
21 May, 2024 4
21 May, 2024 4
13 May, 2024 SC 13G
13 May, 2024 8-K
9 May, 2024 ARS
8 May, 2024 SC 13D
8 May, 2024 10-Q
8 May, 2024 8-K
1 May, 2024 3
30 Apr, 2024 8-K
29 Apr, 2024 DEF 14A
29 Apr, 2024 DEFA14A
22 Mar, 2024 10-K/A
7 Mar, 2024 4
7 Mar, 2024 4
7 Mar, 2024 4
7 Mar, 2024 4
5 Mar, 2024 10-K/A
4 Mar, 2024 SC 13D/A
29 Feb, 2024 8-K
29 Feb, 2024 10-K
22 Feb, 2024 4
22 Feb, 2024 4
14 Feb, 2024 SC 13G/A
13 Feb, 2024 SC 13G/A
13 Feb, 2024 SC 13G/A
9 Feb, 2024 SC 13G
22 Jan, 2024 4
22 Jan, 2024 SC 13G/A
10 Jan, 2024 3
22 Nov, 2023 4
17 Nov, 2023 4
13 Nov, 2023 S-8
6 Nov, 2023 8-K
1 Nov, 2023 8-K
1 Nov, 2023 10-Q
31 Aug, 2023 4
31 Aug, 2023 4
31 Aug, 2023 3
25 Aug, 2023 8-K
7 Aug, 2023 8-K
2 Aug, 2023 4
2 Aug, 2023 8-K
2 Aug, 2023 10-Q
2 Aug, 2023 3
11 Jul, 2023 SC 13D/A
11 Jul, 2023 8-K CEO Change
7 Jun, 2023 4
30 May, 2023 4
24 May, 2023 4
24 May, 2023 4
24 May, 2023 4
24 May, 2023 4
24 May, 2023 4
24 May, 2023 8-K
24 May, 2023 8-K
24 May, 2023 4
23 May, 2023 4
19 May, 2023 4
19 May, 2023 4/A
17 May, 2023 DEFA14A
15 May, 2023 4
15 May, 2023 SC 13D/A
15 May, 2023 3
9 May, 2023 10-Q
9 May, 2023 8-K
1 May, 2023 8-K
1 May, 2023 DEFA14A
28 Apr, 2023 DEF 14A
28 Apr, 2023 ARS
17 Apr, 2023 4
20 Mar, 2023 10-K/A
14 Mar, 2023 4
28 Feb, 2023 10-K
28 Feb, 2023 8-K
22 Feb, 2023 4
14 Feb, 2023 SC 13G
13 Feb, 2023 SC 13G/A
10 Feb, 2023 SC 13G/A
9 Feb, 2023 SC 13G/A
2 Feb, 2023 SC 13G/A
26 Jan, 2023 SC 13G/A
20 Jan, 2023 SC 13G
12 Jan, 2023 4
10 Jan, 2023 SC 13D/A
6 Jan, 2023 3
4 Jan, 2023 8-K
22 Nov, 2022 4
9 Nov, 2022 10-Q
9 Nov, 2022 8-K
28 Oct, 2022 8-K/A
14 Sep, 2022 8-K
26 Aug, 2022 3
23 Aug, 2022 8-K
22 Aug, 2022 8-K
22 Aug, 2022 SC TO-T/A
22 Aug, 2022 4
16 Aug, 2022 SC TO-T/A
27 Jul, 2022 8-K
27 Jul, 2022 10-Q
25 Jul, 2022 SC TO-T
20 Jul, 2022 8-K
13 Jul, 2022 8-K
13 Jul, 2022 4
11 Jul, 2022 425
11 Jul, 2022 SC 13G/A
11 Jul, 2022 SC 13D/A
11 Jul, 2022 8-K
11 Jul, 2022 8-K
11 Jul, 2022 SC TO-C
8 Jul, 2022 SC 13E3/A
8 Jul, 2022 SC TO-T/A
17 Jun, 2022 SC TO-T/A
17 Jun, 2022 CORRESP
17 Jun, 2022 SC 13E3/A
7 Jun, 2022 SC TO-T
7 Jun, 2022 SC 13E3
24 May, 2022 SC TO-C
24 May, 2022 8-K
24 May, 2022 SC TO-C
24 May, 2022 SC 13D/A
23 May, 2022 4
5 May, 2022 10-Q
4 May, 2022 4
4 May, 2022 8-K/A
2 May, 2022 8-K
29 Apr, 2022 8-K
28 Apr, 2022 8-K
27 Apr, 2022 4
27 Apr, 2022 4
27 Apr, 2022 4
27 Apr, 2022 4
27 Apr, 2022 4
27 Apr, 2022 4
7 Apr, 2022 8-K
1 Apr, 2022 8-K
1 Apr, 2022 4
1 Apr, 2022 SC 13D/A
25 Mar, 2022 8-K
25 Mar, 2022 DEF 14A
21 Mar, 2022 8-K
17 Mar, 2022 10-K/A
15 Mar, 2022 SC 13D/A
8 Mar, 2022 8-K
2 Mar, 2022 4
28 Feb, 2022 10-K
23 Feb, 2022 4
22 Feb, 2022 SC 13D/A
22 Feb, 2022 4
11 Feb, 2022 4
11 Feb, 2022 SC 13D/A
11 Feb, 2022 SC 13G/A
10 Feb, 2022 SC 13G/A
9 Feb, 2022 8-K
2 Feb, 2022 SC 13D/A
1 Feb, 2022 SC 13G
28 Jan, 2022 SC 13G/A
13 Dec, 2021 8-K
22 Nov, 2021 4
1 Nov, 2021 4
1 Nov, 2021 SC 13D/A
27 Oct, 2021 8-K
27 Oct, 2021 10-Q
24 Aug, 2021 4/A
23 Aug, 2021 4
29 Jul, 2021 10-Q
28 Jul, 2021 8-K
14 Jun, 2021 SC 13D/A
11 Jun, 2021 4
7 Jun, 2021 SC 13G/A
26 May, 2021 8-K
25 May, 2021 4
25 May, 2021 SC 13D/A
25 May, 2021 SC 13D/A
25 May, 2021 4
24 May, 2021 4
24 May, 2021 4
20 May, 2021 4
20 May, 2021 4
20 May, 2021 4
20 May, 2021 4
20 May, 2021 4
20 May, 2021 4
20 May, 2021 4
20 May, 2021 8-K
20 May, 2021 8-K
5 May, 2021 DEFA14A
3 May, 2021 SC 13D/A
28 Apr, 2021 8-K
28 Apr, 2021 10-Q
5 Apr, 2021 SC 13D/A
2 Apr, 2021 DEF 14A
30 Mar, 2021 4
30 Mar, 2021 4
24 Mar, 2021 4
17 Mar, 2021 4
17 Mar, 2021 SC 13D/A
16 Mar, 2021 3
10 Mar, 2021 8-K
25 Feb, 2021 10-K
22 Feb, 2021 4
12 Feb, 2021 SC 13D/A
11 Feb, 2021 SC 13G/A
10 Feb, 2021 SC 13G/A
3 Feb, 2021 8-K
28 Jan, 2021 4
27 Jan, 2021 SC 13G/A
27 Jan, 2021 SC 13D/A
Last update:2025-03-06 12:24:57.171124

Sign Up to Subscribe